PharmaVOICE Blog Post

Evidera launches OffTheShelf ™ for historic patient data

Posted By: Dan Limbach
October 26, 2020

Learn more about the detailed patient points and associated physician data available from OffTheShelf. View our infographic. http://bit.ly/evidera-offtheshelf

Highlights about OffTheShelf™:

  • Understanding the market trends, market behavior, and competition when developing oncology therapies is critical to optimize market access and product uptake
  • OffTheShelf™ provides access to oncology and hematology patient chart data in 48 hours from 40+ countries across 25+ indications to give you the insights you need to make informed decisions about your product
  • HIPAA and GDPR-compliant, OffTheShelf’s data is sourced from healthcare provider EMR databases and provides more than 100 points per patient

This de-identified data includes

  • detailed patient profiles
  • diagnosis history
  • biomarker testing
  • adjuvant/neoadjuvant therapy
  • complete line of therapy sequencing
  • treatment duration by line
  • Data can be used to answer key product-related questions, including
    • what are the current treatment patterns for my indication?
    • are there gaps within current guidelines?
    • what products have recently launched and what is the uptake?

Please complete the form below to let us know what kind of OffTheShelf™ data you need to better understand the market behavior and competition surrounding your oncology/hematology therapy: http://bit.ly/evidera-survey

About the Blog Poster: Dan Limbach

Post a Comment

You must be logged in to post a Comment.

FEEDBACK